Roles
- Professor of Clinical Medicine
- Assistant Director of Clinical Research/ Medical Director of Nurse Practitioner Oncology Fellowship Program
- Medical Director of Patient Education
-
Biography
Dr. D’Amato is a Professor of Medicine at the Sylvester Comprehensive Cancer Center at the University of Miami, where she serves as a Sarcoma Medical Oncologist, Assistant Director of Clinical Research, Medical Director of Nurse Practitioner Oncology Fellowship Program and Medical Director of Patient Education. She also serves as the Co-Director of Oncology and Related Health Disparities Pathway and Co-Director of Oncology Pathology Advanced Integrative Science Elective at the University of Miami Miller School of Medicine.
She received her B.S. from University of Miami, M.D. from the University of Miami School of Medicine and completed her internal medicine residency at Jackson Memorial Hospital/University of Miami. In 2003, during her last year of hematology/oncology fellowship at Moffitt Cancer Center in Tampa, FL, she began her focus on sarcomas including GIST and benign connective tissue tumors such as desmoid tumor, chordoma and giant cell tumors. In addition to her clinical service, she is also involved in early phase clinical trials for those indications. Recently, she was awarded to be the administrator of the Horowitz Solitary Fibrous Tumor Initiative Fund. -
Education & Training
Education
Post Graduate Training
Licensures and Certifications
-
Honors & Awards
-
Teaching Interests
She serves as Medical Director of Nurse Practitioner Oncology Fellowship Program and Medical Director of Patient Education. She also serves as the Co-Director of Oncology and Related Health Disparities Pathway and Co-Director of Oncology Pathology Advanced Integrative Science Elective at the University of Miami Miller School of Medicine. She is very involved with patient advocacy groups and often performs global lectures and webinars to patients, caregivers as well as healthcare providers. -
Research Interests
Phase 1, 2 and 3 clinical trials in sarcoma including GIST and benign connective tissue tumors such as desmoid tumor, chordoma and giant cell tumors. She was awarded to be the administrator of the Horowitz Solitary Fibrous Tumor Initiative Fund. -
Publications
Disclaimer: Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.Professional Activities
Articles & News
How Sylvester’s Horowitz Initiative Is Advancing Sarcoma Treatment Through Clinical Trials and Precision Medicine
Genetic Pattern May Identify Which Solitary Fibrous Tumors are More Aggressive
Study Examines Wearable Tech and Exercise for Pediatric and Young Adult Sarcoma Care
Disclaimer:
Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.